Design and Synthesis of N -[(4-Methoxyphenoxy)carbonyl]- N -[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with Efficacious Glucose and Lipid-Lowering Activities

Full text: Unavailable

Publisher: American Chemical Society

Preprint: archiving restricted: Upload

  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines

Postprint: archiving restricted: Upload

  • If mandated by funding agency or employer/ institution
  • If mandated to deposit before 12 months, must obtain waiver from Institution/Funding agency or use AuthorChoice
  • 12 months embargo

Published version: archiving forbidden. Upload

Policy details (opens in a new window). Data provided by SHERPA/RoMEO